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Summary
It has been thought that early inner cell mass (ICM) is
a homogeneous population and that cell position in
the ICM leads to the formation of two lineages, epiblast
(EPI) and primitive endoderm (PE), by E4.5. Here, how-
ever, we show that the ICM at E3.5 is already heteroge-
neous. The EPI- and PE-specific transcription factors,
Nanog and Gata6, were expressed in the ICM in a ran-
dom ‘‘salt and pepper’’ pattern, as early as E3.5, in
a mutually exclusive manner. Lineage tracing showed
predominant lineage restriction of single ICM cells at
E3.5 to either lineage. In embryos lacking Grb2 where
no PE forms, Gata6 expression was lost and all ICM
cells were Nanog positive. We propose a model in
which the ICM develops as amosaic of EPI and PE pro-
genitors at E3.5, dependent on Grb2-Ras-MAP kinase
signaling, followed by later segregation of the progen-
itors into the appropriate cell layers.
Introduction
By the time of implantation, three distinct cell types are
apparent in the mouse blastocyst which give rise to sep-
arate cell lineages in later development. Epiblast (EPI)
gives rise to the entire fetus as well as extraembryonic
mesoderm. Trophectoderm (TE) gives rise to all the tro-
phoblast cell types that make up the majority of the fetal
part of the placenta, and the primitive endoderm (PE)
forms the extraembryonic endoderm layers of the vis-
ceral and parietal yolk sacs. The TE and PE extraembry-
onic lineages are required to support the growth of the
mammalian fetus in the uterine environment and are
sources of signals to the EPI to initiate axial patterning
(Ang and Constam, 2004; Beddington and Robertson,
1998; Lu et al., 2001; Rossant and Tam, 2004).
By the late blastocyst, experimental chimera studies
have indicated that the three lineages are restricted to
their future fate (Gardner, 1985; Rossant et al., 2003)
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of the three lineages are still not well understood. At
the eight-cell stage, all blastomeres retain the potential
to form all cell lineages (Johnson and McConnell,
2004). Following compaction, the blastomeres become
polarized and subsequent cell divisions generate out-
side polar cells and inside apolar cells, dependent
upon the symmetric or asymmetric cell divisions of the
polarized cells (Johnson et al., 1986). Polar cells remain
outside and will form the TE, while apolar cells become
enclosed by the polarized outer epithelium and form the
inner cell mass (ICM). This segregation is accompanied
by segregated expression of key transcription factors
(TFs) required to establish cell fate, such as Oct4 (Nich-
ols et al., 1998) and Cdx2 (Chawengsaksophak et al.,
1997; Strumpf et al., 2005) for ICM and TE, respectively.
Correct segregation of the two lineages is also depen-
dent upon cell adhesion, involving E-cadherin (De Vries
et al., 2004; Riethmacher et al., 1995), and the epithelial
polarity pathway, involving genes such as Par3 and
aPKC (Plusa et al., 2005).
Much less is known about the segregation of EPI and
PE within the ICM. By E4.5, the PE layer is clearly mor-
phologically distinct. When E4.5 EPI or PE cells were
dissociated and injected into other blastocysts, their
chimeric contributions were restricted to their own line-
ages (Gardner, 1982, 1984; Gardner and Rossant, 1979),
indicating lineage restriction by this stage. Isolated E3.5
ICMs form PE over their exterior surface (Hogan and
Tilly, 1978; Rossant, 1975), suggesting that EPI/PE seg-
regation might also depend on some positional effects,
with cells located in the inside of ICM becoming EPI and
the cells lining the blastocoel becoming PE.
Recent genetic evidence has implicated Nanog and
Gata family transcriptional factors in specifying EPI ver-
sus PE fate. Nanog, a homeodomain protein, was iden-
tified as a gene highly expressed in ES cells (Mitsui et al.,
2003), which could substitute for LIF to promote self-re-
newal of ES cells (Chambers et al., 2003). Disruption of
this gene leads to failure to maintain pluripotency in ES
cells in vitro and peri-implantation lethality with failure
of EPI formation in vivo (Mitsui et al., 2003). In both ES
cells and ICMs from null mutants, loss of Nanog results
in all cells taking up a parietal endoderm-like fate (Mitsui
et al., 2003). This suggests that levels of Nanog expres-
sion are important for the EPI/PE fate decision. In a com-
plementary manner, overexpression of Gata6 or a close
family member Gata4 is sufficient to transform ES cells
to PE lineages (Fujikura et al., 2002) and ES cells lacking
Gata6 or Gata4 cannot form a functional visceral endo-
derm layer in in vitro embryoid body cultures (Koutsour-
akis et al., 1999; Morrisey et al., 1998; Soudais et al.,
1995). In vivo, Gata4 and Gata6 mutants initiate PE line-
age formation, but fail to form functional visceral endo-
derm in postimplantation embryos (Koutsourakis et al.,
1999; Morrisey et al., 1998; Soudais et al., 1995). Gata4
and Gata6 may be redundantly required for PE formation
in vivo.
In this study, we have carefully examined the expres-
sion of Nanog and Gata6 in early development and have
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neous and complementary in the ICM as early as E3.5,
although not in any obvious position-dependent man-
ner. Cell lineage and chimera studies also support the
concept that the E3.5 ICM is a mosaic of EPI and PE pro-
genitors. We also show that signaling through Grb2 is re-
quired for the segregation of these progenitors at E3.5,
becauseGrb2mutants, which fail to generate PE (Cheng
et al., 1998), show conversion of all cells of the E3.5 ICM
to Nanog-expressing EPI. These results suggest a
reevaluation of the timing and mechanism of EPI/PE
segregation in the mouse ICM is warranted.
Results
‘‘Salt and Pepper’’ Expression of Nanog and Gata6
in the ICM of E3.5 Blastocysts
We examined protein and mRNA expression of the EPI
and PE lineage-related transcription factors Gata6,
Nanog, and Oct4 (Chambers et al., 2003; Koutsourakis
et al., 1999; Mitsui et al., 2003; Nichols et al., 1998) at
E3.5–E4.5 using laser confocal microscopy. Expression
of Gata6 and Oct4 are clearly segregated to the PE and
EPI, respectively, by E4.5 (Figure 1A). Using a heterozy-
gous lacZ knock-in Gata6 mutant mouse, Koutsourakis
et al. reported Gata6 expression at the E3.5 blastocyst
stage in a portion of ICM cells as well as in some tropho-
blast (Koutsourakis et al., 1999). With fluorescent in situ
hybridization and immunohistochemistry, we found
Gata6 and Nanog mRNA and protein expression at
high levels in subsets of cells within the E3.5 ICM (Fig-
ures 1B–1E). Oct4 was expressed at equivalent levels
in all ICM cells at this stage (Figure 1G). No other PE
markers such as Pem, Hex, or Dab2 could be detected
at this stage (data not shown). Double in situ hybridiza-
tion revealed that domains of Gata6 and Nanog expres-
sion were mainly exclusive (Figure 1F), suggesting that
the ICM is a mosaic of Nanog+ and GATA6+ cells. There
was no apparent spatial restriction of Nanog+ or
GATA6+ cells to particular regions of the ICM; rather,
the ICM showed a random ‘‘salt and pepper’’ pattern
of expression of the two genes. This mosaic expression
of two functionally important lineage-specific transcrip-
tion factors suggested the possibility that there might be
lineage segregation of EPI and PE progenitors as early
as the E3.5 ICM.
Labeled Single ICM Cells in Early Blastocysts Give
Rise to Either EPI or PE at E5.5
To address the question of when EPI and PE progenitors
are set aside in development, we reexamined the fate of
single ICM cells in E3.5 blastocysts prior to morpholog-
ical evidence of PE formation. Initially, we microinjected
GFP mRNA into single ICM cells (Weber et al., 1999) and
followed the development of labeled clones postimplan-
tation. Although this technique has been used success-
fully to study PE clonal distributions (Weber et al., 1999),
we found that the high proliferation rate of EPI cells led
to dilution of the GFP mRNA and difficulties in unambig-
uously identifying contributions of labeled cells to EPI
(data not shown). To avoid the problem of dilution, we in-
jected mRNA for the Cre recombinase along with a small
amount of tracer GFP mRNA into single ICM cells of em-
bryos derived from ICR females crossed with Z/EG re-porter males (Novak et al., 2000). In the Z/EG line, GFP
expression from a strong ubiquitous promoter is acti-
vated only after Cre excision is induced. Hence the prog-
eny of the Cre mRNA-injected cell is labeled by GFP per-
manently. Three hundred fifty-eight embryos were
injected and 186 embryos, selected because they had
single GFP-positive cells in ICM at 1 hr after injection,
were transferred into recipient mothers. At E5.5, 146 em-
bryos were recovered and 45 embryos out of 146 were
GFP positive (Table 1). Examination by confocal micros-
copy revealed that progeny of labeled cells contributed
to either EPI (Figure 2A) or PE (Figure 2B) lineage but
never both: 18 embryos had GFP cells only in EPI and
24 embryos only in PE (n = 45; Figure 2C).
This result suggested that in the E3.5 blastocyst, the
fate of single ICM cells is to become either EPI or PE.
This lineage tracing experiment does not address, how-
ever, whether single cells are restricted in their potential
when placed in different environments. To test this, we
isolated single GFP-expressing cells dissociated from
immunosurgically isolated early E3.5 ICMs (the mean
number of cells in ICM is 13.8 cells) and injected them
into ICR blastocysts. Injected cells were from embryos
heterozygous for a ubiquitously expressed GFP trans-
gene (Hadjantonakis et al., 1998). Of the 30 embryos
containing GFP-positive cells recovered at E5.5 (Table
2), 14 embryos showed GFP-positive cells only in the
EPI and 15 embryos showed GFP-positive cells only in
the PE lineage (Figure 2D). Only 1 embryo had GFP con-
tributions in both lineages. This was consistent with the
previous cell-tracing data.
This suggested restriction of cell potential in individ-
ual E3.5 ICM cells. However, it is also possible that in-
jected cells did not have enough time to divide and
contribute to more than one lineage before lineage
restriction at E4.5. Thus, we also aggregated single
ICM cells with eight-cell stage embryos so that the do-
nor ICM cell has the opportunity to divide before forma-
tion of the host ICM lineages. When such aggregates
were cultured to the blastocyst stage, one to four
GFP-positive cells were observed in the embryos. Thir-
teen out of 167 GFP-positive blastocysts had GFP cells
in TE and were not used. One hundred forty-seven em-
bryos were transferred and 75 embryos were recovered
at E5.5. Sixty were GFP positive (Table 3). Nineteen em-
bryos had GFP cells restricted to EPI and 36 embryos
showed restriction to the PE lineage. Only 5 embryos
had GFP cells in both lineages (Figure 2E).
Thus, both lineage tracing and chimera analysis sug-
gest that EPI/PE cell fate restriction is largely initiated
by the early blastocyst stage—1 full day before these tis-
sues are recognizable morphologically.
Lineage Segregation Is Not Based on Either
Blastomere History or Position in the E3.5 ICM
It is important to ask whether the apparent lineage bias
seen at E3.5 is related to the position of cells in the ICM,
as cells lining the surface of the ICM have been thought
to become PE. However, attempts to reproducibly inject
surface versus enclosed cells of the E3.5 ICM were not
successful. Moreover, later examination of aggregated
blastocysts in culture showed that cells did not neces-
sarily maintain their position. Time-lapse movies re-
vealed considerable movement and displacement of
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617Figure 1. ‘‘Salt and Pepper’’ Expression of
Nanog and Gata6 in the ICM of E3.5 Blasto-
cysts
Fluorescent whole-mount in situ hybridiza-
tion (A–C, F, and G) and fluorescent whole-
mount immunostaining (D and E).
(A and B) Gata6 (red) and Oct4 (blue) expres-
sion in the E4.5 implanting embryo (A) and the
E3.5 blastocyst (B).
(C) Nanog expression in the E3.5 blastocyst.
(D) Gata6 immunostaining (red) in the E3.5
blastocyst. Gata6 was detected in some
ICM cells. Nuclei (green) were stained by
YOYO1 in the right panel. White arrows indi-
cate Gata6-negative ICM cells.
(E) Nanog immunostaining (red) in the E3.5
blastocyst. Nanog was detected in some
ICM cells. Neither Nanog nor Gata6 staining
was localized to a specific area within ICM.
(F) Double in situ hybridization with Gata6
(red) and Nanog (blue) in the E3.5 blastocyst.
Most of the cells were expressing either
Nanog or Gata6. A few cells were weakly co-
expressing both markers.
(G) Double in situ hybridization with Gata6
(red) and Oct4 (blue) in the E3.5 blastocyst.cells over time (see Supplemental Data available with
this article online). As another way to label the blasto-
coel-facing surface of the ICM, we labeled single blasto-
meres at the two-cell stage, then selected those in which
the progeny of one of the two-cell blastomeres has con-
tributed to the polar TE and inner cells of the ICM, while
the other cell contributed progeny to the mural TE and
the surface of the ICM (Gardner, 2001; Piotrowska
et al., 2001). In this way, surface cells can be labeled
and their potential assessed in aggregation experiments
such as those described above.
One of the blastomeres of two-cell stage embryos ex-
pressing GFP ubiquitously was labeled with DiI noninva-
sively (Piotrowska et al., 2001). Blastocysts were recov-ered 2 days after transfer to the oviduct and those
embryos that showed a clear boundary between prog-
eny of the individual two-cell blastomeres at the embry-
onic-abembryonic border were selected for further use
(Figure 3A). ICMs were isolated from these embryos
and DiI-labeled and -nonlabeled cells were counted. In
all embryos, both two-cell blastomeres contributed to
the ICM and there was no significant difference in the
contribution derived from the embryonic or abem-
bryonic blastomere (abembryonic ICM cells/embryonic
ICM cells = 0.916 0.07; n = 12). Single isolated ICM cells
from either the embryonic or abembryonic side were
separately aggregated with eight-cell embryos (Table
4). No statistically significant bias was observed in theTable 1. Single ICM Cell Labeling with Cre mRNA Injection into Z/EG Blastocysts
Number of
Injected Embryos
Number of
Blastocysts
with Single
GFP-Positive Cells
Number of
Transferred
Embryos
Number of
Embryos
Recovered at E5.5
Number of Embryos
Containing
GFP-Positive
Progeny
at E5.5
358 186 186 146 45
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cysts Give Rise to Either EPI or PE Lineage
at E5.5
(A and B) Representative embryos with GFP-
positive cells in EPI (A) or visceral endoderm
(B).
(C–E) Number of embryos with GFP-positive
cells in EPI or PE lineage in Cre + GFP
mRNA microinjection (C), single ICM cells
blastocyst injection (D), and single ICM mor-
ula aggregation (E).contribution of the embryonic- versus abembryonic-de-
rived cells to EPI or PE and, as before, the majority of
embryos showed restricted contribution from the single
cell to one lineage or the other (Figure 3B). Thus, there is
no evidence that lineage segregation is based on either
blastomere history or position of cells in the E3.5 ICM.
Receptor Tyrosine Kinase Signaling Is Required
for Segregation of Lineages in the ICM
Grb2 is an adaptor molecule that plays an important role
in signal transduction downstream of several different
receptor tyrosine kinases (Pawson and Scott, 1997).
Mutation of Grb2 leads to loss of the ability to form the
PE lineages in embryos in vivo and in embryoid bodies
in vitro (Cheng et al., 1998). We reexamined the early
phenotype of Grb22/2 embryos in detail using markers
of EPI and PE lineages. No morphologically distinct PE
was apparent in mutants at E4.5 but a homogeneous,
compact ICM was found (Figures 4A–4C). Moreover,
none of the PE markers such as Pem (n = 7), Hex (n =
2), and Dab2 (n = 3) were expressed at E4.5 in Grb22/2
embryos (Figures 4A–4C) but all the remaining ICM cells
expressedOct4 (Figure 4A; n = 5). AsGata6 is expressed
at E3.5 before the PE becomes morphologically appar-
ent (Figures 1 and 4D), we examined whether Gata6 ex-
pression was initiated at all in Grb22/2 mutants. At E3.5,
Grb22/2 blastocysts were morphologically completely
normal but Gata6 expression was absent by in situ
hybridization (n = 5) and immunohistology (n = 5)
(Figure 4D and data not shown). In contrast, NanogmRNA (Figure 4E; n = 5) and Nanog protein (Figure 5A)
were expressed at uniformly high levels in all ICM cells
of E3.5 Grb22/2 embryos (Figures 4E and 5A), rather
than patchily as in wild-type embryos.
Cell counts were performed on stacks of confocal z-
series images to determine whether there was a selec-
tive loss of Nanog-negative cells in E3.5 Grb2 mutants
by counting the number of ICM cells (Figure 5B). Be-
cause it was difficult to collect absolutely identical
stage-matched litters, embryos were compared within
litters. Litter 1 contained mostly expanding blastocysts,
while litter 2 contained mostly fully expanded blasto-
cysts. In the first litter, ICM cell numbers were 16.3 6
2.8 in mutants (n = 7) and 16.9 6 1.9 in wild-type em-
bryos (n = 6). In the second litter, ICM numbers were
28.5 in mutants (n = 2) and 24.6 6 1.5 in wild-type (n =
5). In both cases, there was no significant statistical dif-
ference in the number of ICM cells between mutant and
wild-type.
Next, we examined the percentage of cells expressing
high levels of Nanog in ICMs (Figure 5C). In litter 1, the
percentage of Nanog-positive cells was 44.7 6 7.5 in
wild-type and 74.3 6 7.0 in mutants. In litter 2, the
slightly later stage embryos, the percentage of positive
cells was 49.7 6 3.7 in wild-type (n = 5) and 100 in mu-
tants (n = 2).
These results suggest that all E3.5 ICM cells take up
a Nanog+ EPI fate in Grb22/2 mutants and indicate
that establishing lineage segregation requires signaling
through Grb2.Table 2. Single Early ICM Cell Injection into Blastocysts
Number of Injected Embryos Number of Transferred Embryos
Number of Embryos
Recovered at E5.5
Number of Embryos
Containing GFP-Positive Progeny
at E5.5
210 210 123 30
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619Table 3. Single Early ICM Cells Aggregated with Morula Embryos
Number of Embryos
Aggregated
Number of
GFP-Positive
Blastocysts
Number of
Transferred
Embryos
Number of
Embryos
Recovered at E5.5
Number of
Embryos
Containing
GFP-Positive
Progeny at E5.5
366 167: 147 75 60
154 in ICM
13 inTE
Discussion
The idea of position driving cell fate segregation in the
ICM of the mouse blastocyst has long held sway, as
the primitive endoderm is recognized as a monolayer
on the surface of the ICM directly facing the blastocoel.
In addition, in isolated ICMs (Hogan and Tilly, 1978; Ros-
sant, 1975) and in ES cell-derived embryoid bodies, an
in vitro model of PE formation (Murray and Edgar,
2004), the PE lineage forms on the outer surface of the
embryoid bodies (EBs). However, there are few experi-
mental data to suggest how position might drive cell
fate determination in the ICM. In this study, we carefully
analyzed the onset of expression of the PE- and EPI-
specific TFs, Gata6 and Nanog, before these two line-
ages are morphologically distinct. Expression of each
TF was detected in a subset of cells in E3.5 blastocysts.
No consistent spatial pattern was observed—the two
genes were expressed in a complementary ‘‘salt and
pepper’’ manner. In addition, lineage tracing and chi-
mera data showed that the majority of single early E3.5
ICM cells were already restricted to be either EPI or
PE. Although some early ICM cells were capable of gen-
erating both EPI and PE when placed back in the eight-
cell stage embryo, the predominant pattern was of re-
stricted fate, suggesting that there is heterogeneity in
the E3.5 ICM. These results suggest that there is
a need to consider an alternative model for segregationof the two ICM lineages, perhaps not by position in the
ICM.
The best way to test whether the position in the E3.5
ICM is important for PE formation would be to directly la-
bel the surface versus enclosed cells in the ICM. We at-
tempted that, but it was hard to judge the precise location
of injected cells in living embryos. Instead, we used em-
bryos in which one of the two-cell blastomeres had
been labeled by lipophilic dye and showed a clear two-
cell progeny boundary across the embryonic-abem-
bryonic axisof the blastocyst. In these embryos, a surface
layer of ICM derived from one of the two-cell blastomeres
could be distinguished from the enclosed cells of ICM de-
rived from the other blastomere. This allowed us to ana-
lyze the developmental potential of surface or enclosed
ICM cells. There was no evidence from these experiments
that position of cells in ICM related to their later fate.
Furthermore, the results of the single ICM cell blasto-
cyst injection chimeras also supported the lack of influ-
ence of cell position. If position in the ICM were impor-
tant, one would expect a bias toward PE contribution,
because the injected cells were always positioned on
the surface of ICM after injection. However, no such
bias was observed: the results showed almost equiva-
lent contributions to either EPI or PE. Therefore, both
gene expression and experimental analysis provide ev-
idence for a new model of generation of the E3.5 ICM
as a mosaic of EPI and PE progenitors, with laterFigure 3. Potential between ICM Cells from the Embryonic Side and Abembryonic Side to Contribute to EPI or PE
(A) Method used for labeling surface ICM cells.
(B) Comparison of the number of embryos with GFP-positive cells contributing to EPI or PE between ICM cells derived from the embryonic or the
abembryonic side. There was no significant statistical difference between these cells (P < 0.05, Chi-squared test) in their ability to contribute to
PE or EPI.
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620Table 4. Single ICM Cells Aggregated with Morula Embryos
Number of
Embryos Aggregated
Number of GFP-Positive
Blastocysts Transferred
Number of Embryos
Recovered at E5.5
Number of Embryos
Containing GFP-Positive
Progeny at E5.5
Abembryonic 76 35 11 8
Embryonic 83 41 22 21segregation of these EPI and PE progenitors into appro-
priate positions. Proof of a direct relationship between
TF expression profile and lineage restriction, however,
will await the development of new tools, such as GFP fu-
sion knock-in alleles of Nanog and Gata6, that will allow
us to trace directly the fate and potential of cells ex-
pressing the specific TFs in the future.
What mechanism could regulate establishment of the
two lineage progenitors in early blastocysts? Two
groups have suggested the possibility that the progeny
from the two different blastomeres at the two-cell stage
may have different fates or potencies, as their progeny
tend to colonize either the embryonic or abembryonic
side of the blastocyst (Gardner, 2001; Piotrowska
et al., 2001). However, our results showed no difference
in potential to form EPI and PE between the progeny of
the different two-cell blastomeres (Figure 3B). Another
possibility is that the cleavage pattern during the 8- to
32-cell stage may create this difference. Inner cells, fu-
ture ICM cells, are produced from two successive
rounds of asymmetric division, from the 8- to 16- and
16- to 32-cell stage (Johnson and McConnell, 2004).
An attractive model would suggest that EPI and PE de-
rive separately from these two successive rounds of
asymmetric division. This idea was originally suggested
by Chisholm and Houliston (1987). They analyzed the lo-
calization of the extraembryonic lineage-specific cyto-
keratin (ENDO-A) in early embryos using the TROMA-1
antibody. They showed that those cells in the ICM of
early blastocysts, which did possess filaments, were al-
most exclusively the apolar progeny of polar 16-cell
blastomeres rather than progeny of apolar blastomeresgenerated at the 8- to 16-cell stage. However, this model
has never been rigorously tested.
Our evidence strongly suggests that the lineage seg-
regation requires receptor tyrosine kinase (RTK)-Ras-
MAP kinase signaling. In Grb2 mutants, lack of activa-
tion of this signaling pathway caused all early ICM cells
to become Nanog positive and no PE was formed. Inter-
estingly, homozygous mutants of Fgf4 and Fgfr2 cannot
form PE and have very similar phenotypes to Grb2 mu-
tants (Arman et al., 1998; Feldman et al., 1995; Wilder
et al., 1997). Although lineage markers have not been ex-
amined in those mutants, the similar phenotypes sug-
gest that FGF signaling might be the major RTK pathway
involved upstream of Grb2. Furthermore, EBs from ES
cells overexpressing a dominant-negative Fgf receptor
construct cannot differentiate into PE but this pheno-
type can be rescued by overexpression of Gata factors
(Li et al., 2004). This result suggests that activation of
Gata factor expression is the key PE-promoting element
downstream of RTK-Grb2 signaling. Because Nanog
protein is initially found throughout the early embryo
(Strumpf et al., 2005; data not shown) and then becomes
restricted to a subset of ICM cells as Gata6 expres-
sion begins, Fgf signaling through Grb2 may promote
PE formation by activating Gata6 expression, which
leads secondarily to loss of Nanog expression. Fgf4,
Fgfr2, and Grb2 are expressed throughout the ICM (Ar-
man et al., 1998; Niswander and Martin, 1992; Rappolee
et al., 1994; data not shown), so restricted localization
does not explain how Gata6 expression becomes het-
erogeneous in the ICM. Individual ICM cells may acquire
differential sensitivity to RTK-Ras-MAPK activationFigure 4. Absence of PE in Grb22/2 Embryos
Embryos on the left are Grb2+/+ or Grb2+/2
and on the right are Grb22/2. There was no
morphologically apparent PE layer in mutant
E4.75 embryos (A–C).
(A) Expression of Oct4 (red) and Pem (blue).
(B) Expression of Hex (red) and Pem (blue).
(C) Expression of Dab2 (red). Neither PE
marker was expressed in Grb22/2 embryos
at E4.75.
(D) Expression of Gata6 (red) and Oct4 (blue)
in the E3.5 blastocyst.
(E) Expression of Nanog (red) at E3.5. Gata6
expression was not detected but Nanog ex-
pression was detected in all ICM cells in
Grb22/2 embryos. Expression of Oct4 was
not affected in Grb22/2 embryos (D).
ExE, extraembryonic ectoderm; ICM, inner
cell mass; PrE, primitive endoderm; Tr, tro-
phoblast.
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Grb22/2 Embryos
(A) Immunostaining of Nanog and Cdx2 in
Grb2+/2 (upper panels) and Grb22/2 (lower
panels). All ICM cells in Grb22/2 expressed
Nanog (red in merged image).
(B) Number of ICM cells in wild-type and mu-
tant blastocysts. Nuclei (YOYO3-blue) were
counted as ICM if they did not express Cdx2
(green). There was no significant difference
in total number of ICM cells between Grb2+/+
and Grb2+/2 (blue bar) and Grb22/2 embryos
(purple bar). Numbers of embryos in individ-
ual samples are shown inside of bars.
(C) The percentage of strong Nanog-positive
cells in the ICM. In early blastocysts (litter 1),
there are strong and weak Nanog-positive
cells in the ICM. However, in expanding blas-
tocysts (litter 2), we did not detect weak pos-
itive cells anymore.(Figure 6), perhaps based on a combination of their line-
age derivation during cleavage and their interactions
with each other and with the TE.
How could EPI and PE progenitors be sorted out from
a ‘‘salt and pepper’’ pattern to a separate EPI and PE
layer? XEN cells, newly identified PE-derived stem cell
lines (Kunath et al., 2005), form derivatives of the PE line-
age only when they are injected into blastocysts. When
XEN cells are aggregated with ES cells in suspension cul-
ture, they form EB-like structures in which XEN cells and
ES cells sort out such that XEN cells always surround the
outside of ES cells (M. Ryczko and J.R., unpublished
data), the same arrangement as occurs in the developing
ICM. Thus, EPI and PE cells must have different adhesive
characteristics that allow them to sort out from each
other. In ES cells, Gata overexpression leads to a strong
upregulation of LamininB1, which changes the adhesion
properties ofGata-expressing cells (Fujikura et al., 2002).
Interestingly, there are several targeted mouse mutants
in genes involved in cell adhesion and cell migration
that fail to generate a cohesive PE layer. These include
Dab2 (Morris et al., 2002; Yang et al., 2002), a PTB do-main-containing adaptor protein, Maspin (Gao et al.,
2004), a noninhibitory Serpin family protein and a putative
tumor suppressor, LamC1 (Smyth et al., 1999), an ECM
protein, and integrin b1 (Stephens et al., 1995), a cell ad-
hesion molecule. In all cases, scattered cells labeled with
PE markers can be detected in the middle of ICM of these
mutants. These results suggest that PE lineage progeni-
tors were formed in these mutants but that there was
a failure of the mechanism necessary to ensure that the
PE cells are segregated to the surface of the ICM. Inter-
estingly, Dab2 has been shown to be a direct target of
Gata6 (Morrisey et al., 2000). Dab2 modulates the cellular
adhesiveness during megakaryocytic differentiation of
the human chronic myeloid leukemic cell line K562
(Tseng et al., 2003) and transiently interacts with integrin
b1 to regulate its activation during transforming growth
factor b-induced epithelial to mesenchymal transition in
normal murine mammary gland cells (Prunier and
Howe, 2005). These suggest that activation of pathways
leading to appropriate cell sorting is one of the key roles
for early expression ofGata6 in PE progenitors in the E3.5
ICM (Figure 6).Figure 6. Model of EPI/PE Formation
The ICM of E3.5 blastocysts is a mosaic of
EPI progenitors and PE progenitors. Grb2-
dependent signals (likely Fgf signal) induce
Gata and repress Nanog in PE progenitors,
although the mechanism of selective activa-
tion of this pathway in PE progenitors is
unknown. The absence of Grb2-dependent
signals allows Nanog expression in EPI pro-
genitors. In PE progenitors, Gata induces tar-
get genes such as Laminin and Dab2, which
modulate cellular adhesive function to initiate
the sorting of the two lineages. By E4.5, the
basal lamina (consisting mainly of Laminin)
forms and separates the two lineages.
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PE lineage in chimeras, even though they can produce
PE-like cells in EBs (Beddington and Robertson, 1998).
ES cells thus behave like EPI progenitors in chimeras
but behave as bipotential progenitors in vitro. Unlike
the embryo itself, where PE formation is an early event
and limited in its duration, PE formation from ES cells
takes several days and requires changes in either growth
factor conditions (Murray and Edgar, 2004) or direct al-
teration of levels of expression of Nanog (Mitsui et al.,
2003) or Gata6 (Fujikura et al., 2002). It seems likely that
the same downstream TF pathways used in the early em-
bryo are reactivated in ES cells to drive PE formation but
the upstream mechanisms activating expression are dif-
ferent. When placed in the blastocyst environment, ES
cells do not respond by making PE but behave as re-
stricted EPI cells, consistent with this proposal. Future
experiments combining live cell imaging with cell fate
analysis and genetic interventions will help determine
what mechanisms are used to drive early lineage segre-
gation in the embryo and will lead to better understand-
ing of lineage development and cell behavior.
Experimental Procedures
Microinjection of mRNA into Single Cells of Preimplantation
Embryos
Capped mRNAs were synthesized according to the manufacturer’s
protocol (MEGAscript; Ambion), using pCS2 EGFP and pCS2
CreNLS as templates. Both plasmids were linearized by NotI and
transcribed mRNA using SP6 RNA polymerase.
For microinjection, we used a Leica microscope (Leica Microsys-
tems) andmanipulators withFemtoJet (Eppendorf) forpressure injec-
tion and a Cyto721 intracellular amplifier (WPI) was used to create the
negative capacitance. The injection was performed in an open glass
chamber in M2 solution. ICM cells were injected through either the
polar or mural TE. Injected embryos were cultured for 1 hr in KSOM
solution in a 5% CO2 incubator and GFP expression was checked
under a fluorescent UV microscope. Only embryos that had single
GFP cells were transferred to pseudopregnant recipient mothers.
Immunosurgery and Dissociation of ICM
Early blastocysts were flushed from the uteri of the ICR females
crossed with B5 males expressing GFP ubiquitously (Hadjantonakis
et al., 1998). Immunosurgery was performed according to Nagy et al.
(2003). Briefly, the zona was removed with acid-tyrode solution, em-
bryos were treated with nonabsorbed rabbit anti-mouse lymphocyte
cells antibody (Cedarlane), and diluted 1 in 6 to 1 in 10 in KSOM, for
10 min in a CO2 incubator at 37ºC. After five washes with M2, they
were treated with complement (Cedarlane) diluted 1 in 6 to 1 in 10
in KSOM. Embryos were observed periodically under the dissecting
microscope to check lysis of outer cells. Usually, we observed clear
membrane blebbing of TE within 10–15 min. ICMs were then washed
in M2 and treated with 1% trypsin in PBS-EDTA to dissociate them to
single cells. Collected single cells were used for morula aggregation
or blastocyst injection.
Lipophilic Dye Labeling
DiI or DiA (Molecular Probes) was dissolved in corn oil. A small drop-
let of dye solution was deposited on one of the two-cell blastomeres
using the microinjection system. Embryos were transferred to the
oviducts of recipients and flushed from uteri 2 days later at the blas-
tocyst stage. We checked the distribution of labeled progeny in blas-
tocysts using a UV fluorescent microscope and selected embryos
exhibiting a boundary of two-cell progenies at the embryonic-abem-
bryonic border.
Whole-Mount Immunostaining
Embryos collected from the oviduct or the uterus by flushing were
fixed with 4% paraformaldehyde (PFA) in PBS overnight at 4ºC. Em-bryos were permeabilized with 0.5% Triton X100 in PBS for 15 min.
Embryos were blocked in 10% fetal bovine serum in PBS-0.1% Tri-
ton for 1 hr. We used mouse anti-Cdx2 monoclonal Ab, 1/100 dilution
(BioGenex, Cdx288), rabbit anti-Nanog polyclonal Ab, 1/200 dilution
(a gift from Dr. S. Yamanaka, Japan and Cosmo Bio, Japan), and rab-
bit anti-Gata6 Abs, 1/200 dilution (a gift from Dr. M. Nemer, Mon-
treal). Fluorophore-conjugated secondary Abs were purchased
from Jackson Immuno Research and Molecular Probes.
To counterstain nuclei, embryos were treated with 10 mM YOYO1
or YOYO3 (Molecular Probes) in PBS with 200 mg/ml RNaseA.
Fluorescent Whole-Mount In Situ Hybridization
A detailed protocol can be found on the Rossant lab home
page (http://www.sickkids.ca/rossant/protocols/doubleFluor.asp).
Briefly, after flushing or dissection, embryos were fixed with 4%
PFA in PBS overnight at 4ºC and stored in methanol at 220ºC. Em-
bryos were rehydrated with 0.1% Tween 20 in PBS (PBT) and per-
meabilized with RIPA solution (150 mM NaCl, 1% Nonidet P-40,
0.5% sodium deoxycolate, 0.1% SDS, 1 mM EDTA, 50 mM Tris
[pH 8.0]) for 10–20 min at room temperature (RT). Embryos were
postfixed with 4% PFA + 0.2% glutaraldehyde for 10 min at RT,
and prehybridized in hybridization buffer (50% formamide, 53
SSC, 1% SDS, 100 mg/ml yeast tRNA, 50 mg/ml heparin) for 1 hr
at 65ºC. Hybridization with probes was done overnight at 65ºC. Em-
bryos were washed twice for 30 min with 50% formamide, 53 SSC,
1% SDS, once for 20 min with 50% formamide, 23 SSC, 1% SDS for
20 min at 65ºC, and then transferred to PBT. Embryos were blocked
with manufacturer’s blocking solution for 1–2 hr at RT. Embryos
were treated with anti-DIG or -FITC antibody conjugated to peroxi-
dase (1/200; Roche) overnight at 4ºC. Fluorescent staining with
TSA-Cy3, -Cy5 kits was carried out according to the manufacturer’s
instructions (Perkin Elmer). Embryos were treated with tyramide-
Cy3 or -Cy5 (1/50 in amplification diluent) for 30–60 min in the dark
at RT. For the second color reaction, the first antibody was inacti-
vated in 0.1 M glycine-HCl (pH 2.2), 0.1% Tween 20 for 10 min and
the procedures were repeated from the blocking step. To amplify
the staining, a TSA-biotin amplification kit (Perkin Elmer) was used.
Confocal Microscopy
Zeiss LSM 510 and Leica TCS2 confocal microscopes fitted with
Zeiss Fluar 203 (NA = 0.75) or Leica HC PL APO 203 (NA = 0.70)
were used for capturing images. The pinhole was set to 1–1.2 Airy
unit and a series of optical sections was taken for all samples. Em-
bryos were mounted in wells of Secure Seal (Molecular Probes) be-
tween two cover glasses for observation.
Genotyping of Blastocysts
Genotyping of blastocysts was performed after confocal microscopy
as follows. Embryos were lysed in 10 ml of DNA solution with protein-
ase K for 15 min at 65ºC, then treated at 100ºC for 5 min to inactivate
proteinase K. Three microliters of DNA solution was used in a 20 ml
PCR reaction. Primer pairs used for Grb2 genotyping were 50-TT
GGGTCCAGGTGAACACGAGGA-30 with 50-CCTTCTATCGCCTTCTT
GACGAG-30 for the mutant allele and 50-TTGGGTCCAGGTGAACACG
AGGA-30 with 50- CAGAGCCAGGTAAGAGCCCCAG- 30 for the wild-
type allele. An annealing temperature of 60ºC and Advantage Taq
(Clontech) were used for all PCR reactions.
Supplemental Data
Supplemental Data including one figure and a time-lapse movie are
available at http://www.developmentalcell.com/cgi/content/full/10/
5/615/DC1/.
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Note Added in Proof
A paper was recently published online supporting the molecular het-
erogeneity in the E3.5 ICM (Kurimoto, K., Yabuta, Y., Ohinata, Y.,
Ono, Y., Uno, K.D., Yamada, R.G., Ueda, H.R., and Saitou, M.
2006. An improved single-cell cDNA amplification method for effi-
cient high-density oligonucleotide microarray analysis. Nucl. Acids
Res. 34, e42).
